Submit Deal

SERB PHARMACEUTICALS

HQ - Brussels

Summary

SERB is a global specialty pharmaceutical company with a growing portfolio of medicines for emergency care and rare diseases.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 58 M

Avg. Deal Size£ 58 M

Market Context

Senior Management

Sort

Target: EMERGENT BIOSOLUTIONS (REACTIVE SKIN DECONTAMINATION LOTION ASSETS)

Bidder: CHARTERHOUSE CAPITAL PARTNERS

4 Service Providers

2 Dealmakers

£ 58 M

Value

Target: AURLUMYN

Bidder: SERB PHARMACEUTICALS

3 Service Providers

6 Dealmakers

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy